2023
DOI: 10.1371/journal.pgen.1010952
|View full text |Cite
|
Sign up to set email alerts
|

Neurodevelopmental deficits and cell-type-specific transcriptomic perturbations in a mouse model of HNRNPU haploinsufficiency

Sarah A. Dugger,
Ryan S. Dhindsa,
Gabriela De Almeida Sampaio
et al.

Abstract: Heterozygous de novo loss-of-function mutations in the gene expression regulator HNRNPU cause an early-onset developmental and epileptic encephalopathy. To gain insight into pathological mechanisms and lay the potential groundwork for developing targeted therapies, we characterized the neurophysiologic and cell-type-specific transcriptomic consequences of a mouse model of HNRNPU haploinsufficiency. Heterozygous mutants demonstrated global developmental delay, impaired ultrasonic vocalizations, cognitive dysfun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 91 publications
0
1
0
Order By: Relevance
“…Saf-a knockout mouse models show embryonic lethality 36 , whilst conditional deletion in the developing brain leads to rapid cell death of both postmitotic neurons and neural progenitors 37 . Saf-a haploinsufficiency also affects the expression of the neuropeptides arginine vasopressin (Avp) and vasoactive intestinal polypeptide (Vip) resulting in changes in metabolic activity 38 and cell type specific changes in transcription 39,40 . SAF-A is also clinically relevant, as patients with mutations in the gene have neurodevelopmental disorders 17,[41][42][43] .…”
Section: Introductionmentioning
confidence: 99%
“…Saf-a knockout mouse models show embryonic lethality 36 , whilst conditional deletion in the developing brain leads to rapid cell death of both postmitotic neurons and neural progenitors 37 . Saf-a haploinsufficiency also affects the expression of the neuropeptides arginine vasopressin (Avp) and vasoactive intestinal polypeptide (Vip) resulting in changes in metabolic activity 38 and cell type specific changes in transcription 39,40 . SAF-A is also clinically relevant, as patients with mutations in the gene have neurodevelopmental disorders 17,[41][42][43] .…”
Section: Introductionmentioning
confidence: 99%